| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $66.8M | -14.7% |
| SG&A Expense | $31.5M | -1.5% |
| Interest Expense | $3K | +0.0% |
| Pre-tax Income | -$97.2M | +11.1% |
| Income Tax | $1K | +0.0% |
| Net Income | -$97.2M | +11.1% |
| EPS (Basic) | -$2.52 | +14.6% |
| EPS (Diluted) | -$2.52 | +14.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.8M | -67.5% |
| Short-term Investments | $39.7M | +78.0% |
| Current Assets | $78.0M | -36.2% |
| Total Assets | $155.0M | -22.5% |
| Current Liabilities | $16.3M | -3.6% |
| Total Liabilities | $76.6M | +69.8% |
| Stockholders' Equity | $78.4M | -49.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$80.7M | -32.5% |
| Capital Expenditures | $885K | -97.5% |
| Investing Cash Flow | $12.5M | -85.9% |
| Financing Cash Flow | $3.9M | -28.3% |
| Free Cash Flow | -$81.6M | +15.0% |